Synthesis of Novel 5′-Uridine-Head Amphiphiles as Model for DNA Molecular Recognition
摘要:
Here we describe uridine functionalization in the 5' position, which provides new classes of cationic and nonionic amphiphiles specifically designed. as DNA transfection agents. The Synthetic procedures developed to obtain the cationic uridine-head surfactants prevented intramolecular cyclization. that occurs when. uridine is functionalized in this position without using protecting groups in the uracil.
Synthesis of Novel 5′-Uridine-Head Amphiphiles as Model for DNA Molecular Recognition
摘要:
Here we describe uridine functionalization in the 5' position, which provides new classes of cationic and nonionic amphiphiles specifically designed. as DNA transfection agents. The Synthetic procedures developed to obtain the cationic uridine-head surfactants prevented intramolecular cyclization. that occurs when. uridine is functionalized in this position without using protecting groups in the uracil.
SUGAR MODIFIED OLIGONUCLEOTIDES THAT DETECT AND MODULATE GENE EXPRESSION
申请人:ISIS PHARMACEUTICALS, INC.
公开号:EP0549615A1
公开(公告)日:1993-07-07
EP0549615A4
申请人:——
公开号:EP0549615A4
公开(公告)日:1997-08-27
[EN] SUGAR MODIFIED OLIGONUCLEOTIDES THAT DETECT AND MODULATE GENE EXPRESSION
申请人:ISIS PHARMACEUTICALS, INC.
公开号:WO1992003568A1
公开(公告)日:1992-03-05
(EN) Compositions and methods are provided for the treatment and diagnosis of diseases amenable to modulation of the production of selected proteins. In accordance with preferred embodiments, oligonucleotides and oligonucleotide analogs are provided which are specifically hybridizable with a selected sequence of RNA or DNA wherein at least one of the 2'-deoxyfuranosyl moieties of the nucleoside unit is modified. Treatment of HIV, herpes virus, papillomavirus and other infections is provided.(FR) Compositions et procédés de traitement et de diagnostic de maladies en corrélation avec la modulation de la production de protéines sélectionnées. Selon des modes de réalisation préférés, des oligonucléotides ainsi que des analogues d'oligonucléotides sont spécifiquement hybridables avec une séquence sélectionnée d'ARN ou d'ADN dans laquelle au moins une des fractions 2'-désoxyfuranosyl de l'unité de nucléoside est modifiée. L'invention concerne également le traitement du VIH, du virus herpétique, du virus du papillome ainsi que d'autres infections.